心血管基因组和蛋白组



心血管基因组和蛋白组
心血管的基因组和蛋白质组是研究相应组学在心血管系统的特定表现，通过对其研究以深入了解心血管疾病的发病机制和治疗靶点，从而提高心血管疾病的防治工作的水平。此次CMBI特准备了关于心血管基因组和蛋白组相关文献，供大家参考。更多文献，请用相关关键词通过CMBI文献查询获取。
Urinary proteomics-a tool to discover biomarkers of kidney diseases Proteomics in atherothrombosis Proteome analysis of myocardial tissue following ischemia and reperfusion Application of proteomics in cardiovascular medicine Survivin Regulation of Vascular Injury Ischemia-specific phosphorylation and myofilament translocation of heat shock protein 27 precedes alpha B-crystallin and occurs independently of reactive oxygen species in rabbit myocardium Transcriptome analysis of the ischemia-reperfused remodeling myocardium Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease Recent Developments in Proteomics Quest for novel cardiovascular biomarkers by proteomic analysis Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis Proteomic approach in the search of new cardiovascular biomarkers Proteomic analysis of human vessels-application to atherosclerotic plaques Proteomic analysis of differential protein expression in human atherosclerotic plaque progression Proteomic analysis of diet-induced hypercholesterolemic Inhibition of LINE-1 expression in the heart decreases ischemic damage by activation of Akt-PKB signaling Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems Genetic background affects cardiovascular responses to obstructive and simulated apnea Elimination of allosteric modulation of myocardial KATP channels by ATP and protons in two Kir6.2 polymorphisms found in sudden cardiac death Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation Cardiovascular-related proteins Cardiovascular phenotyping of fetal mice by noninvasive high-frequency ultrasound facilitates recovery of ENU-induced mutations causing congenital cardiac and extracardiac BDNF-mediated enhancement of inflammation and injury in the aging heart Application of proteomics in cardiovascular Analysis of Intimal Proteoglycans in Atherosclerosis-prone and Atherosclerosis-resistant Human Arteries by Mass Spectrometry Reduced serine–16 and threonine–17 phospholamban phosphorylation in stunning of conscious dogs Overexpression of sarcolipin decreases myocyte contractility and calcium transient Multi-Tasking RGS Proteins in the Heart Rho Kinases in Cardiovascular Physiology and Pathophysiology Proteomics of the Heart Using models of the myocyte for functional interpretation of cardiac proteomic data Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure Emerging studies of the urinary proteome Candidate-based proteomics in the search for biomarkers of cardiovascular disease Heart disease, clinical proteomics and mass spectrometry. Using models of the myocyte for functional interpretation of cardiac proteomic data Candidate-based proteomics in the search for biomarkers of cardiovascular disease The Platelet Microparticle Proteome Quest for Novel Cardiovascular Biomarkers by Proteomic Analysis Prediction of G-Protein-Coupled Receptor Classes Vascular endothelial growth factor pharmacogenetics Cardiovascular therapy and pharmacogenetics in 2007 Reviews of Translational Medicine and Genomics in Cardiovascular Disease-New Disease Taxonomy and Therapeutic Implications In Search of New Targets for Plasma High-Density Lipoprotein Cholesterol Levels Application of pharmacogenomics in the prevention of diabetic cardiovascular disease In Search of New Targets for Plasma High-Density Lipoprotein Cholesterol Levels Case-control studies in the genomic era-a clinician's guide Genomic Analysis of Circulating Cells-A Window Into Atherosclerosis Gene Expression Analysis of Cardiovascular Diseases-Novel Insights Into Biology and Clinical Applications Integrating genetic and gene expression data-application to cardiovascular using the myocardial transcriptome as a biomarker in cardiovascular disease The genetic basis for cardiac remodeling Pharmacogenetics and Heart disease Pharmacogenomics of cholesterol-lowering therapy Pharmacogenetics-Progress, pitfalls and clinical potential for coronary heart disease Pharmacogenetics of multigenic disease Pharmacogenetics of antihypertensive treatment Pharmacogenetics and cardiac ion channels Pathway analysis of coronary atherosclerosis Novel Integrative Approaches to the Identification of Candidate Genes in Hypertension Molecular mechanisms of inherited cardiomyopathies Importance of blood cellular genomic profile in coronary heart disease HIF-1-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart Genetic contributors toward increased risk for ischemic heart disease Gene expression analysis of ischemic and nonischemic cardiomyopathy-shared and distinct genes in the development of heart failure Functional genomics of the dopaminergic system in hypertension Expressed genome molecular signatures of heart failure environment interactions in the molecular pathogenesis of dilated cardiomyopathy DNA Microarray Analysis for Human Congenital Heart Disease Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure Cardiovascular Genomics Cardiomyopathies-is it time for a molecular classification Cardiac myocyte differentiation Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy arrhy-Genomics and Cardiac Arrhythmias Array lessons from the heart A physiogenomic approach to study the regulation of blood pressure and transcriptome of cardiomyopathies wide association study to identify SNPs conferring risk of myocardial infarction Genome-Wide Screening for Target Regions of Histone Deacetylases in Cardiomyocytes What have we learnt about microarray analyses of atherogenesis wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses

Last Modified: 2008-01-14